Hypoxia: How does the monocyte-macrophage system respond to changes in oxygen availability?

Journal of Leukocyte Biology

Volumn 95, Issue 2, 2014, Pages 233-241

  Strehl, Cindy ^a,b   Fangradt, Monique ^a,b   Fearon, Ursula ^c   Gaber, Timo ^a,b,d   Buttgereit, Frank ^a,b,d   Veale, Douglas J ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b German Rheumatism Research Center   (Germany)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d Berlin Brandenburg Center for Regenerative Therapies   (Germany)

Author keywords

Blood; Bone marrow; HIF 1a; HIF 2a; Maturation; Tissue

Indexed keywords

OXYGEN;

ANGIOGENESIS; BLOOD; BONE DESTRUCTION; BONE MARROW; CARTILAGE DEGENERATION; CELL DIFFERENTIATION; CELL ENERGY; CELL FUNCTION; CELL INVASION; CELL METABOLISM; CELL SURVIVAL; ENDOTHELIUM CELL; ENERGY METABOLISM; EXTRAVASATION; FACE; HUMAN; HYPOXIA; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROPHAGE; MATURATION; MICROENVIRONMENT; MONOCYTE; MONOCYTE MACROPHAGE PRECURSOR CELL; MYELOID PROGENITOR CELL; OXYGEN CONCENTRATION; OXYGEN SUPPLY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYNOVIOCYTE; SYNOVIUM; ANIMAL; ANOXIA; DRUG EFFECT; HIF-1Α; HIF-2Α; PATHOLOGY; RHEUMATOID ARTHRITIS; TISSUES;

BLOOD; BONE MARROW; HIF-1Α; HIF-2Α; MATURATION; TISSUE;

ANIMALS; ANOXIA; ARTHRITIS, RHEUMATOID; BONE MARROW; HUMANS; MACROPHAGES; MONOCYTES; OXYGEN;

EID: 84897027837     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1212627     Document Type: Review

References (96)

1. Lund-Olesen, K. (1970) Oxygen tension in synovial fluids. Arthritis Rheum. 13, 769-776.
2. Tsai, A. G., Cabrales, P., Intaglietta, M. (2010) The physics of oxygen delivery: facts and controversies. Antioxid. Redox Signal. 12, 683-691.
3. Buttgereit, F., Burmester, G. R., Brand, M. D. (2000) Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol. Today 21, 192-199.
4. Serviddio, G., Sastre, J. (2010) Measurement of mitochondrial membrane potential and proton leak. Methods Mol. Biol. 594, 107-121.
5. Ng, C. T., Biniecka, M., Kennedy, A., McCormick, J., FitzGerald, O., Bresnihan, B., Buggy, D., Taylor, C. T., O'Sullivan, J., Fearon, U., Veale, D. J. (2010) Synovial tissue hypoxia and inflammation in vivo. Ann. Rheum. Dis. 69, 1389-1395.
6. Tripmacher, R., Gaber, T., Dziurla, R., Haupl, T., Erekul, K., Grutzkau, A., Tschirschmann, M., Scheffold, A., Radbruch, A., Burmester, G. R., Buttgereit, F. (2008) Human CD4(+) T cells maintain specific functions even under conditions of extremely restricted ATP production. Eur. J. Immunol. 38, 1631-1642.
7. Gaber, T., Haupl, T., Sandig, G., Tykwinska, K., Fangradt, M., Tschirschmann, M., Hahne, M., Dziurla, R., Erekul, K., Lautenbach, M., Kolar, P., Burmester, G. R., Buttgereit, F. (2009) Adaptation of human CD4+ T cells to pathophysiological hypoxia: a transcriptome analysis. J. Rheumatol. 36, 2655-2669.
8. Law, R., Bukwirwa, H. (1999) The physiology of oxygen delivery. In Update in Anaesthesia, 10th ed., World Federation of Societies of Anaesthesiologists, London, UK.
9. Semenza, G. L. (2001) Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7, 345-350.
10. Sitkovsky, M., Lukashev, D. (2005) Regulation of immune cells by localtissue oxygen tension: HIF1 α and adenosine receptors. Nat. Rev. Immunol. 5, 712-721.
11. Bergers, G., Song, S. (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 7, 452-464.
12. Kennedy, A., Ng, C. T., Biniecka, M., Saber, T., Taylor, C., O'Sullivan, J., Veale, D. J., Fearon, U. (2010) Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum. 62, 711-721.
13. Battaglia, F., Delfino, S., Merello, E., Puppo, M., Piva, R., Varesio, L., Bosco, M. C. (2008) Hypoxia transcriptionally induces macrophage-inflammatory protein-3α/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-κB. J. Leukoc. Biol. 83, 648-662.
14. Chow, D. C., Wenning, L. A., Miller, W. M., Papoutsakis, E. T. (2001) Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model. Biophys. J. 81, 675-684.
15. Chow, D. C., Wenning, L. A., Miller, W. M., Papoutsakis, E. T. (2001) Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys. J. 81, 685-696.
16. Ishikawa, Y., Ito, T. (1988) Kinetics of hemopoietic stem cells in a hypoxic culture. Eur. J. Haematol. 40, 126-129.
17. Villarruel, S. M., Boehm, C. A., Pennington, M., Bryan, J. A., Powell, K. A., Muschler, G. F. (2008) The effect of oxygen tension on the in vitro assay of human osteoblastic connective tissue progenitor cells. J. Orthop. Res. 26, 1390-1397.
18. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
19. Cipolleschi, M. G., Dello Sbarba, P., Olivotto, M. (1993) The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 82, 2031-2037.
20. Semenza, G. L., Wang, G. L. (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447-5454.
21. Wang, G. L., Jiang, B. H., Rue, E. A., Semenza, G. L. (1995) Hypoxiainducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92, 5510-5514.
22. Wang, G. L., Semenza, G. L. (1993) General involvement of hypoxiainducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA 90, 4304-4308.
23. Dehne, N., Brune, B. (2009) HIF-1 in the inflammatory microenvironment. Exp. Cell. Res. 315, 1791-1797.
24. Gaber, T., Dziurla, R., Tripmacher, R., Burmester, G. R., Buttgereit, F. (2005) Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do! Ann. Rheum. Dis. 64, 971-980.
25. Fangradt, M., Hahne, M., Gaber, T., Strehl, C., Rauch, R., Hoff, P., Lohning, M., Burmester, G. R., Buttgereit, F. (2012) Human monocytes and macrophages differ in their mechanisms of adaptation to hypoxia. Arthritis Res. Ther. 14, R181.
26. Imhof, B. A., Aurrand-Lions, M. (2004) Adhesion mechanisms regulating the migration of monocytes. Nat. Rev. Immunol. 4, 432-444.
27. Lingnau, M., Hoflich, C., Volk, H. D., Sabat, R., Docke, W. D. (2007) Interleukin-10 enhances the CD14-dependent phagocytosis of bacteria and apoptotic cells by human monocytes. Hum. Immunol. 68, 730-738.
28. Muniz-Junqueira, M. I., Tosta, C. E. (2009) Stages of in vitro phagocytosis of Plasmodium falciparum-infected erythrocytes by human monocytes. Rev. Soc. Bras. Med. Trop. 42, 103-106.
29. Bosco, M. C., Puppo, M., Santangelo, C., Anfosso, L., Pfeffer, U., Fardin, P., Battaglia, F., Varesio, L. (2006) Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxiainducible gene. J. Immunol. 177, 1941-1955.
30. Roiniotis, J., Dinh, H., Masendycz, P., Turner, A., Elsegood, C. L., Scholz, G. M., Hamilton, J. A. (2009) Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J. Immunol. 182, 7974-7981.
31. Elbarghati, L., Murdoch, C., Lewis, C. E. (2008) Effects of hypoxia on transcription factor expression in human monocytes and macrophages. Immunobiology 213, 899-908.
32. Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., Mantovani, A., Melillo, G., Sica, A. (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198, 1391-1402.
33. Bosco, M. C., Puppo, M., Pastorino, S., Mi, Z., Melillo, G., Massazza, S., Rapisarda, A., Varesio, L. (2004) Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages. J. Immunol. 172, 1681-1690.
34. Bosco, M. C., Reffo, G., Puppo, M., Varesio, L. (2004) Hypoxia inhibits the expression of the CCR5 chemokine receptor in macrophages. Cell. Immunol. 228, 1-7.
35. Vallabhapurapu, S., Karin, M. (2009) Regulation and function of NF-κB transcription factors in the immune system. Ann. Rev. Immunol. 27, 693-733.
36. Oliver, K. M., Garvey, J. F., Ng, C. T., Veale, D. J., Fearon, U., Cummins, E. P., Taylor, C. T. (2009) Hypoxia activates NF-κB-dependent gene expression through the canonical signaling pathway. Antioxid. Redox Signal. 11, 2057-2064.
37. Nakazato, K., Ishibashi, T., Nagata, K., Seino, Y., Wada, Y., Sakamoto, T., Matsuoka, R., Teramoto, T., Sekimata, M., Homma, Y., Maruyama, Y. (2001) Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia. Atherosclerosis 155, 439-444.
38. Melillo, G., Sausville, E. A., Cloud, K., Lahusen, T., Varesio, L., Senderowicz, A. M. (1999) Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytes. Cancer Res. 59, 5433-5437.
39. Gao, W., Sweeney, C., Walsh, C., Rooney, P., McCormick, J., Veale, D. J., Fearon, U. (2013) Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2. Ann. Rheum. Dis. 72, 1080-1088.
40. Gao, W., Sweeney, C., Connolly, M., Kennedy, A., Ng, C. T., McCormick, J., Veale, D. J., Fearon, U. (2012) Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum. 64, 2104-2113.
41. Gustafsson, M. V., Zheng, X., Pereira, T., Gradin, K., Jin, S., Lundkvist, J., Ruas, J. L., Poellinger, L., Lendahl, U., Bondesson, M. (2005) Hypoxia requires Notch signaling to maintain the undifferentiated cell state. Dev. Cell 9, 617-628.
42. Diez, H., Fischer, A., Winkler, A., Hu, C. J., Hatzopoulos, A. K., Breier, G., Gessler, M. (2007) Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp. Cell. Res. 313, 1-9.
43. Coleman, M. L., McDonough, M. A., Hewitson, K. S., Coles, C., Mecinovic, J., Edelmann, M., Cook, K. M., Cockman, M. E., Lancaster, D. E., Kessler, B. M., Oldham, N. J., Ratcliffe, P. J., Schofield, C. J. (2007) Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J. Biol. Chem. 282, 24027-24038.
44. Zheng, X., Linke, S., Dias, J. M., Zheng, X., Gradin, K., Wallis, T. P., Hamilton, B. R., Gustafsson, M., Ruas, J. L., Wilkins, S., Bilton, R. L., Brismar, K., Whitelaw, M. L., Pereira, T., Gorman, J. J., Ericson, J., Peet, D. J., Lendahl, U., Poellinger, L. (2008) Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc. Natl. Acad. Sci. USA 105, 3368-3373.
45. Kamakura, S., Oishi, K., Yoshimatsu, T., Nakafuku, M., Masuyama, N., Gotoh, Y. (2004) Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat. Cell. Biol. 6, 547-554.
46. De Hooge, A. S., van de Loo, F. A., Koenders, M. I., Bennink, M. B., Arntz, O. J., Kolbe, T., van den Berg, W. B. (2004) Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. Arthritis Rheum. 50, 2014-2023.
47. Gordon, R. A., Grigoriev, G., Lee, A., Kalliolias, G. D., Ivashkiv, L. B. (2012) The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment. Arthritis Rheum. 64, 3119-3128.
48. Oda, T., Hirota, K., Nishi, K., Takabuchi, S., Oda, S., Yamada, H., Arai, T., Fukuda, K., Kita, T., Adachi, T., Semenza, G. L., Nohara, R. (2006) Activation of hypoxia-inducible factor 1 during macrophage differentiation. Am. J. Physiol. Cell. Physiol. 291, C104-C113.
49. Johnson, J. L., Newby, A. C. (2009) Macrophage heterogeneity in atherosclerotic plaques. Curr. Opin. Lipidol. 20, 370-378.
50. Kohro, T., Tanaka, T., Murakami, T., Wada, Y., Aburatani, H., Hamakubo, T., Kodama, T. (2004) A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. J. Atheroscler. Thromb. 11, 88-97.
51. Sugimoto, K., Toyoshima, H., Sakai, R., Miyagawa, K., Hagiwara, K., Ishikawa, F., Takaku, F., Yazaki, Y., Hirai, H. (1992) Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood 79, 2378-2383.
52. Yang, J., Ahmed, A., Poon, E., Perusinghe, N., de Haven Brandon, A., Box, G., Valenti, M., Eccles, S., Rouschop, K., Wouters, B., Ashcroft, M. (2009) Small-molecule activation of p53 blocks hypoxia-inducible factor 1β and vascular endothelial growth factor expression in vivo and leads to tumor cell apoptosis in normoxia and hypoxia. Mol. Cell. Biol. 29, 2243-2253.
53. Novak, N., Bieber, T., Katoh, N. (2001) Engagement of Fc ∈ RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J. Immunol. 167, 797-804.
54. Bosco, M. C., Puppo, M., Blengio, F., Fraone, T., Cappello, P., Giovarelli, M., Varesio, L. (2008) Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration. Immunobiology 213, 733-749.
55. Mosser, D. M., Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
56. Randolph, G. J., Sanchez-Schmitz, G., Liebman, R. M., Schakel, K. (2002) The CD16(+) (FcγRIII(+) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J. Exp. Med. 196, 517-527.
57. Grage-Griebenow, E., Flad, H. D., Ernst, M. (2001) Heterogeneity of human peripheral blood monocyte subsets. J. Leukoc. Biol. 69, 11-20.
58. Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., Enk, A. H. (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213-1222.
59. Katoh, N., Soga, F., Nara, T., Masuda, K., Kishimoto, S. (2005) Histamine induces the generation of monocyte-derived dendritic cells that express CD14 but not CD1a. J. Invest. Dermatol. 125, 753-760.
60. Rydberg, E. K., Krettek, A., Ullstrom, C., Ekstrom, K., Svensson, P. A., Carlsson, L. M., Jonsson-Rylander, A. C., Hansson, G. I., McPheat, W., Wiklund, O., Ohlsson, B. G., Hulten, L. M. (2004) Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages. Arterioscler. Thromb. Vasc. Biol. 24, 2040-2045.
61. Hollander, A. P., Corke, K. P., Freemont, A. J., Lewis, C. E. (2001) Expression of hypoxia-inducible factor 1α by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum. 44, 1540-1544.
62. Murdoch, C., Giannoudis, A., Lewis, C. E. (2004) Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104, 2224-2234.
63. Rasheed, S., Harris, A. L., Tekkis, P. P., Turley, H., Silver, A., McDonald, P. J., Talbot, I. C., Glynne-Jones, R., Northover, J. M., Guenther, T. (2009) Hypoxia-inducible factor-1α and-2α are expressed in most rectal cancers but only hypoxia-inducible factor-1β is associated with prognosis. Br. J. Cancer 100, 1666-1673.
64. Burke, B., Tang, N., Corke, K. P., Tazzyman, D., Ameri, K., Wells, M., Lewis, C. E. (2002) Expression of HIF-1α by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J. Pathol. 196, 204-212.
65. Hirani, N., Antonicelli, F., Strieter, R. M., Wiesener, M. S., Ratcliffe, P. J., Haslett, C., Donnelly, S. C. (2001) The regulation of interleukin-8 by hypoxia in human macrophages-a potential role in the pathogenesis of the acute respiratory distress syndrome (ARDS). Mol. Med. 7, 685-697.
66. Griffiths, L., Binley, K., Iqball, S., Kan, O., Maxwell, P., Ratcliffe, P., Lewis, C., Harris, A., Kingsman, S., Naylor, S. (2000) The macrophage-a novel system to deliver gene therapy to pathological hypoxia. Gene Ther. 7, 255-262.
67. Grimshaw, M. J., Balkwill, F. R. (2001) Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation-a potential mechanism. Eur. J. Immunol. 31, 480-489.
68. Turner, L., Scotton, C., Negus, R., Balkwill, F. (1999) Hypoxia inhibits macrophage migration. Eur. J. Immunol. 29, 2280-2287.
69. Staples, K. J., Sotoodehnejadnematalahi, F., Pearson, H., Frankenberger, M., Francescut, L., Ziegler-Heitbrock, L., Burke, B. (2011) Monocytederived macrophages matured under prolonged hypoxia transcriptionally up-regulate HIF-1α mRNA. Immunobiology 216, 832-839.
70. White, J. R., Harris, R. A., Lee, S. R., Craigon, M. H., Binley, K., Price, T., Beard, G. L., Mundy, C. R., Naylor, S. (2004) Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. Genomics 83, 1-8.
71. Kuwabara, K., Ogawa, S., Matsumoto, M., Koga, S., Clauss, M., Pinsky, D. J., Lyn, P., Leavy, J., Witte, L., Joseph-Silverstein, J., et al. (1995) Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc. Natl. Acad. Sci. USA 92, 4606-4610.
72. Metinko, A. P., Kunkel, S. L., Standiford, T. J., Strieter, R. M. (1992) Anoxia-hyperoxia induces monocyte-derived interleukin-8. J. Clin. Invest. 90, 791-798.
73. Burke, B., Giannoudis, A., Corke, K. P., Gill, D., Wells, M., Ziegler-Heitbrock, L., Lewis, C. E. (2003) Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am. J. Pathol. 163, 1233-1243.
74. Kennedy, A., Fearon, U., Veale, D. J., Godson, C. (2011) Macrophages in synovial inflammation. Front. Immunol. 2, 52.
75. Burmester, G. R., Stuhlmuller, B., Keyszer, G., Kinne, R. W. (1997) Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis Rheum. 40, 5-18.
76. Vallejo, A. N., Yang, H., Klimiuk, P. A., Weyand, C. M., Goronzy, J. J. (2003) Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction. J. Immunol. 171, 1732-1740.
77. Abeles, A. M., Pillinger, M. H. (2006) The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases. Bull. NYU Hosp. Jt. Dis. 64, 20-24.
78. Athanasou, N. A., Quinn, J., Heryet, A., Puddle, B., Woods, C. G., McGee, J. O. (1988) The immunohistology of synovial lining cells in normal and inflamed synovium. J. Pathol. 155, 133-142.
79. Alvaro-Gracia, J. M., Zvaifler, N. J., Firestein, G. S. (1990) Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-γ and tumor necrosis factor-α on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J. Clin. Invest. 86, 1790-1798.
80. Janusz, M. J., Hare, M. (1993) Cartilage degradation by cocultures of transformed macrophage and fibroblast cell lines. A model of metalloproteinase-mediated connective tissue degradation. J. Immunol. 150, 1922-1931.
81. Bondeson, J. (2010) Activated synovial macrophages as targets for osteoarthritis drug therapy. Curr. Drug Targets 11, 576-585.
82. Veale, D., Yanni, G., Rogers, S., Barnes, L., Bresnihan, B., Fitzgerald, O. (1993) Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum. 36, 893-900.
83. Mulherin, D., Fitzgerald, O., Bresnihan, B. (1996) Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br. J. Rheumatol. 35, 1263-1268.
84. Haringman, J. J., Gerlag, D. M., Zwinderman, A. H., Smeets, T. J. M., Kraan, M. C., Baeten, D., McInnes, I. B., Bresnihan, B., Tak, P. P. (2005) Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann. Rheum. Dis. 64, 834-838.
85. Bresnihan, B., Pontifex, E., Thurlings, R., Vinkenoog, M., El-Gabalawy, H., Fearon, U., FitzGerald, O., Gerlag, D., Rooney, T., van de Sande, M., Veale, D., Vos, K., Tak, P. (2009) Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. J. Rheumatol. 36, 1800-1802.
86. Bodamyali, T., Stevens, C. R., Billingham, M. E., Ohta, S., Blake, D. R. (1998) Influence of hypoxia in inflammatory synovitis. Ann. Rheum. Dis. 57, 703-710.
87. Stevens, C. R., Blake, D. R., Merry, P., Revell, P. A., Levick, J. R. (1991) A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum. 34, 1508-1513.
88. Treuhaft, P. S., McCarty, D. J. (1971) Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. Arthritis Rheum. 14, 475-484.
89. Dingle, J. T., Thomas, D. P. (1956) In vitro studies on human synovial membrane; a metabolic comparison of normal and rheumatoid tissue. Br. J. Exp. Pathol. 37, 318-323.
90. Naughton, D., Whelan, M., Smith, E. C., Williams, R., Blake, D. R., Grootveld, M. (1993) An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy. FEBS Lett. 317, 135-138.
91. Escribese, M. M., Sierra-Filardi, E., Nieto, C., Samaniego, R., Sanchez-Torres, C., Matsuyama, T., Calderon-Gomez, E., Vega, M. A., Salas, A., Sanchez-Mateos, P., Corbi, A. L. (2012) The prolyl hydroxylase PHD3 identifies proinflammatory macrophages and its expression is regulated by activin A. J. Immunol. 189, 1946-1954.
92. Takeda, Y., Costa, S., Delamarre, E., Roncal, C., Leite de Oliveira, R., Squadrito, M. L., Finisguerra, V., Deschoemaeker, S., Bruyere, F., Wenes, M., Hamm, A., Serneels, J., Magat, J., Bhattacharyya, T., Anisimov, A., Jordan, B. F., Alitalo, K., Maxwell, P., Gallez, B., Zhuang, Z. W., Saito, Y., Simons, M., De Palma, M., Mazzone, M. (2011) Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479, 122-126.
93. Takeda, K., Ichiki, T., Narabayashi, E., Inanaga, K., Miyazaki, R., Hashimoto, T., Matsuura, H., Ikeda, J., Miyata, T., Sunagawa, K. (2009) Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-α expression. Arterioscler. Thromb. Vasc. Biol. 29, 2132-2137.
94. Muz, B., Larsen, H., Madden, L., Kiriakidis, S., Paleolog, E. M. (2012) Prolyl hydroxylase domain enzyme 2 is the major player in regulating hypoxic responses in rheumatoid arthritis. Arthritis Rheum. 64, 2856-2867.
95. Werno, C., Menrad, H., Weigert, A., Dehne, N., Goerdt, S., Schledzewski, K., Kzhyshkowska, J., Brune, B. (2010) Knockout of HIF-1β in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses. Carcinogenesis 31, 1863-1872.
96. Mancino, A., Lawrence, T. (2010) Nuclear factor-κB and tumor-associated macrophages. Clin. Cancer Res. 16, 784-789.